This rapid synthesis address the following questions: In patients with COVID-19 and acute hypoxemic ventilatory failure: • What is the effectiveness of administering high oxygen flows (> 15 L / min) to decrease the rate of admission to the Intensive Care Unit (ICU), the need for orotracheal intubation (OTI), and mortality? • What is the effectiveness of administering positive pressure on the airway to decrease the rate of admission to ICU, the need for OTI, and mortality? • What mechanism of high-flow oxygen therapy with or without positive pressure can be safer to reduce intrahospital infection transmission between patients and healthcare staff?
From the PEERSS research team in Colombia
High flow oxygen therapy and continuous positive pressure systems in adult patients with COVID-19

Published in English; Spanish

2020

Rapid Synthesis
